Effects and treatment applications of polymeric nanoparticles on improving platelets’ storage time: a review of the literature from 2010 to 2020

다국어 초록 (Multilingual Abstract)

Maintaining the quality of platelet products and increasing their storage time are priorities for treatment applications. The formation of platelet storage lesions that limit the storage period and preservation temperature, which can prepare a decent environment for bacterial growth, are the most important challenges that researchers are dealing with in platelet preservation. Nanotechnology is an emerging field of science that has introduced novel solutions to resolve these problems. Here, we reviewed the reported effects of polymeric nanoparticles—including chitosan, dendrimers, polyethylene glycol (PEG), and liposome— on platelets in articles from 2010 to 2020. As a result, we concluded that the presence of dendrimer nanoparticles with a smaller size, negative charge, low molecular weight, and low concentration along with PEGylation can increase the stability and survival of platelets during storage. In addition, PEGylation of platelets can also be a promising approach to improve the quality of platelet bags during storage.

참고문헌 (Reference)

1 Dobrovolskaia MA, "Volume 2: haematocompatibility of engineered nanomaterials" World Scientific 261-302, 2016

2 Pedziwiatr-Werbicka E, "Toxicity of gold nanoparticles stabilized by cationic carbosilane dendrons" Belarusian State University 2016

3 Kim Y, "Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine)dendrimers" 19 : 406-411, 2008

4 Cicha I, "Thrombosis : novel nanomedical concepts of diagnosis and treatment" 7 : 434-441, 2015

5 Shrivastava M, "The platelet storage lesion" 41 : 105-113, 2009

6 Gu R, "The performance of a fly-larva shell-derived chitosan sponge as an absorbable surgical hemostatic agent" 31 : 1270-1277, 2010

7 Lord MS, "The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins" 32 : 6655-6662, 2011

8 Franiak-Pietryga I, "The influence of maltotriose-modified poly(propylene imine)dendrimers on the chronic lymphocytic leukemia cells in vitro : dense shell G4PPI" 10 : 2490-2501, 2013

9 Da Silveira Cavalcante L, "The effects of liposome treatment on red blood cells during hypothermic storage" University of Alberta 2017

10 Stadnick H, "The effect of liposome treatment on the quality of hypothermically stored red blood cells" 9 : 335-342, 2011

11 Stadnick HPA, "The deformability of hypothermically stored red blood cells" University of Alberta 2011

12 Jiang G, "Stable nanomicelles based on chitosan derivative : in vitro antiplatelet aggregation and adhesion properties" 88 : 232-238, 2012

13 Greish K, "Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles" 6 : 713-723, 2012

14 Xiong WY, "Selective carboxypropionylation of chitosan : synthesis, characterization, blood compatibility, and degradation" 346 : 1217-1223, 2011

15 Okamura Y, "Release abilities of adenosine diphosphate from phospholipid vesicles with different membrane properties and their hemostatic effects as a platelet substitute" 148 : 373-379, 2010

16 Mehrizi TZ, "Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major" 29 : 125-, 2018

17 He Q, "Positive charge of chitosan retards blood coagulation on chitosan films" 27 : 1032-1045, 2013

18 Zielińska A, "Polymeric nanoparticles : production, characterization, toxicology and ecotoxicology" 25 : 3731-, 2020

19 D’souza AA, "Polyethylene glycol(PEG) : a versatile polymer for pharmaceutical applications" 13 : 1257-1275, 2016

20 Chan LW, "PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage" 31 : 178-185, 2016

21 Knop K, "Poly(ethylene glycol)in drug delivery : pros and cons as well as potential alternatives" 49 : 6288-6308, 2010

22 Dzmitruk V, "Platelets aggregation induced by dendrimers and their complexes with siRNA and ODN, albumins impact on the process" 12 : 139-143, 2015

23 Foster TE, "Platelet-rich plasma : from basic science to clinical applications" 37 : 2259-2272, 2009

24 Kerrigan SW, "Platelet-bacterial interactions" 67 : 513-523, 2010

25 Verma A, "Platelet utilization in the developing world : strategies to optimize platelet transfusion practices" 41 : 145-149, 2009

26 Bakhaidar R, "PLGA-PEG nanoparticles show minimal risks of interference with platelet function of human platelet-rich plasma" 21 : 9716-, 2020

27 Greco CA, "PEGylation prevents bacteria-induced platelet activation and biofilm formation in platelet concentrates" 100 : 336-339, 2011

28 Kim Y, "PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors" 20 : 1888-1898, 2009

29 Zadeh Mehrizi T, "Novel nanosized chitosan-betulinic acid against resistant leishmania major and first clinical observation of such parasite in kidney" 8 : 11759-, 2018

30 Mirzaei M, "Novel nanosized GD3+-ALGD-G2-C595 : in vivo dual selective MUC-1 positive tumor molecular MR imaging and therapeutic agent" 3 : 1000147-, 2012

31 Mehrizi TZ, "Novel nano-sized chitosan amphotericin B formulation with considerable improvement against Leishmania major" 13 : 3129-3147, 2018

32 Árnason NA, "New strategies to understand platelet storage lesion" 12 : 496-500, 2017

33 Šemberová J, "Nanotechnology in the intensive care: intravascular biocompatibility of carbon nanomaterials-effect of carbon nanotubes on blood platelets" Charles University 2012

34 Franiak-Pietryga I, "Nanoparticlesa novel approach to chronic lymphocytic leukemia treatment?" 120 (120): 4601-, 2012

35 Ilinskaya AN, "Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology" 8 : 773-784, 2013

36 Dobrovolskaia MA, "Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro" 9 : 382-393, 2012

37 Enciso AE, "Nanoparticle effects on human platelets in vitro : a comparison between PAMAM and triazine dendrimers" 21 : 428-, 2016

38 Braddock M, "Nanomedicines : design, delivery and detection" Royal Society of Chemistry 2016

39 Beltrán-Gracia E, "Nanomedicine review : clinical developments in liposomal applications" 10 : 11-, 2019

40 Fortunati E, "Nanomaterials for food packaging" Elsevier Inc 71-110, 2018

41 Kim ES, "Nanoencapsulation of red ginseng extracts using chitosan with polyglutamic acid or fucoidan for improving antithrombotic activities" 64 : 4765-4771, 2016

42 Srinivasan M, "Modulatory effects of curcumin on -radiationinduced cellular damage in primary culture of isolated rat hepatocytes" 24 : 98-105, 2007

43 Shi X, "Microspheres of carboxymethyl chitosan, sodium alginate and collagen for a novel hemostatic in vitro study" 30 : 1092-1102, 2016

44 Chen KY, "Mechanics for the adhesion and aggregation of red blood cells on chitosan" 34 : 725-732, 2018

45 Stoll C, "Liposomes composed of unsaturated lipids for membrane modification of human erythrocytes" 28 : 454-461, 2011

46 Akbarzadeh A, "Liposome : classification, preparation, and applications" 8 : 102-, 2013

47 Chan VWT, "Liposomal-encapsulated enzymes can be delivered to and modify platelet function ex vivo" University of British Columbia 2018

48 Ramtoola Z, "Investigation of the interaction of biodegradable micro-and nanoparticulate drug delivery systems with platelets" 63 : 26-32, 2011

49 Zhang Y, "Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis" 7 : 1062-1071, 2017

50 Chitlur M, "Influence of nanopolymers with different end-functionalities on platelet function and the coagulation cascade-an ex-vivo study" (108) : 4038-4038, 2006

51 Ziemba B, "Influence of fourth generation poly(propyleneimine)dendrimers on blood cells" 100 : 2870-2880, 2012

52 Aisina R, "Influence cationic and anionic PAMAM dendrimers of low generation on selected hemostatic parameters in vitro" 109 : 110605-, 2020

53 Li P, "In-situ preparation of aminoterminated dendrimers on TiO2 films by generational growth for potential and efficient surface functionalization" 459 : 438-445, 2018

54 Ziemba B, "In vivo toxicity of poly(propyleneimine)dendrimers" 99 : 261-268, 2011

55 Zadeh Mehrizi T, "In vivo therapeutic effects of four synthesized antileishmanial nanodrugs in the treatment of Leishmaniasis" 13 : e80314-, 2018

56 Periayah MH, "In vitro capacity of different grades of chitosan derivatives to induce platelet adhesion and aggregation" 52 : 244-249, 2013

57 Srinivasan R, "In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes" 93 : 1004-1015, 2010

58 Watala C, "How do the full-generation poly(amido)amine(PAMAM)dendrimers activate blood platelets? Activation of circulating platelets and formation of"fibrinogen aggregates"in the presence of polycations" 503 : 247-261, 2016

59 Wang L, "Hemostatic nanotechnologies for external and internal hemorrhage management" 8 : 4396-4412, 2020

60 Kuznetsova NR, "Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer" 160 : 394-400, 2012

61 Peña-González CE, "Gold nanoparticles stabilized by cationic carbosilane dendrons : synthesis and biological properties" 46 : 8736-8745, 2017

62 Hashempour Alamdari N, "Gd3+-asparagine-anionic linear globular dendrimer secondgeneration G2 complexes : novel nanobiohybrid theranostics" 2017 : 3625729-, 2017

63 Pourshahrestani S, "Galliumcontaining mesoporous bioactive glass with potent hemostatic activity and antibacterial efficacy" 4 : 71-86, 2016

64 de Castro S, "Functionalized congeners of P2Y1 receptor antagonists : 2-alkynyl(N)-methanocarba 2’-deoxyadenosine 3’, 5’-bisphosphate analogues and conjugation to a polyamidoamine(PAMAM)dendrimer carrier" 21 : 1190-1205, 2010

65 Gopalakrishnan L, "Ellagic acid encapsulated chitosan nanoparticles as anti-hemorrhagic agent" 111 : 215-221, 2014

66 Wakamoto S, "Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on agonist-induced platelet aggregation and RANTES release in vitro" 29 : 191-201, 2001

67 Fu Y, "Effects of poly(amidoamine)dendrimers on the structure and function of key blood components" 29 : 165-179, 2014

68 Stohlawetz P, "Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans" 39 : 506-514, 1999

69 Zadeh Mehrizi T, "Effective materials of medicinal plants for leishmania treatment in vivo environment" 19 : 39-62, 2020

70 Bakhaidar R, "Effect of size and concentration of PLGA-PEG nanoparticles on activation and aggregation of washed human platelets" 11 : 514-, 2019

71 da Silveira Cavalcante L, "Effect of liposome-treated red blood cells in an anemic rat model" 27 : 56-63, 2017

72 Shahabi J, "Effect of gold nanoparticles on properties of nanoliposomal hydroxyurea : an in vitro study" 29 : 315-320, 2014

73 Barrios-Gumiel A, "Effect of PEGylation on the biological properties of cationic carbosilane dendronized gold nanoparticles" 573 : 118867-, 2020

74 Liu Y, "Dual-functionalized poly(amidoamine)dendrimers with poly(ethylene glycol)conjugation and thiolation improved blood compatibility" 67 : 1492-1502, 2015

75 Shelma R, "Development of lauroyl sulfated chitosan for enhancing hemocompatibility of chitosan" 84 : 561-570, 2011

76 Vaidya B, "Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents" 403 : 254-261, 2011

77 Roeven E, "Design, synthesis, and characterization of fully zwitterionic, functionalized dendrimers" 4 : 3000-3011, 2019

78 Abbasi E, "Dendrimers : synthesis, applications, and properties" 9 : 247-, 2014

79 Dobrovolskaia MA, "Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge" 7 : 245-256, 2012

80 Scott MD, "Cryopreservationcurrent advances and evaluations" IntechOpen 2019

81 Mirzaei H, "Computational and nonglycosylated systems : a simpler approach for development of nanosized PEGylated proteins" 10 : 1193-1200, 2016

82 Tarrand J, "Compositions and methods for prolonged cell storage" The University of Texas System 2018

83 Zadeh Mehrizi T, "Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major : real-time PCR assay plus" 14 : 7593-7607, 2019

84 Maurer E, "Cold storage of pegylated platelets at about or below 0° C" Canadian Blood Services 2011

85 Alavi SE, "Cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved properties as an anticancer agent" 20 : 1531-, 2019

86 Hu Z, "Chitosan-based composite materials for prospective hemostatic applications" 16 : 273-, 2018

87 Jesus S, "Chitosan nanoparticles : shedding light on immunotoxicity and hemocompatibility" 8 : 100-, 2020

88 Jones CF, "Cationic PAMAM dendrimers disrupt key platelet functions" 9 : 1599-1611, 2012

89 Jones CF, "Cationic PAMAM dendrimers aggressively initiate blood clot formation" 6 : 9900-9910, 2012

90 Chambers P, "Bone repair biomaterials" Woodhead Publishing 411-446, 2019

91 Wang YW, "Biological effects of chitosan-based dressing on hemostasis mechanism" 11 : 1906-, 2019

92 Fernandes EG, "Antithrombogenic properties of bioconjugate streptokinasepolyglycerol dendrimers" 17 : 105-111, 2006

93 Fuentes E, "Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles" 13 : 1089-1094, 2017

94 Alavidjeh MS, "Anionic linear-globular dendrimers : biocompatible hybrid materials with potential uses in nanomedicine" 21 : 1121-1133, 2010

95 Chung TW, "Adenosine diphosphatedecorated chitosan nanoparticles shorten blood clotting times, influencing the structures and varying the mechanical properties of the clots" 9 : 1655-1664, 2014

96 Fröhlich E, "Action of nanoparticles on platelet activation and plasmatic coagulation" 23 : 408-430, 2016

97 Liu H, "A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing" 8 : 7533-7549, 2018